|
Volumn 402, Issue 6, 2012, Pages 2121-2129
|
Use of pneumatic nebulization and laser ablation-inductively coupled plasma-mass spectrometry to study the distribution and bioavailability of an intraperitoneally administered Pt-containing chemotherapeutic drug
|
Author keywords
Biological samples; Chemotherapeutic drugs; Laser ablation ICP mass spectrometry; Platinum; Quantitative mapping
|
Indexed keywords
BEVACIZUMAB;
BIOLOGICAL SAMPLES;
CHEMOTHERAPEUTIC DRUGS;
DRUG PENETRATION;
INTRAPERITONEAL;
INTRAPERITONEALLY;
LASER-ABLATION INDUCTIVELY-COUPLED PLASMA MASS SPECTROMETRY;
LIMITS OF DETECTION;
OXALIPLATIN;
PERITONEAL CARCINOMATOSIS;
PNEUMATIC NEBULIZATION;
QUANTITATIVE MAPPING;
SAMPLE INTRODUCTION;
TISSUE SAMPLES;
TISSUE SECTIONS;
TREATMENT CONDITIONS;
BIOCHEMISTRY;
BLOOD;
DIALYSIS;
INDUCTIVELY COUPLED PLASMA;
LASER ABLATION;
MASS SPECTROMETRY;
PNEUMATICS;
TISSUE;
PLATINUM;
ANTINEOPLASTIC AGENT;
OXALIPLATIN;
PLATINUM COMPLEX;
ANIMAL;
ARTICLE;
BIOAVAILABILITY;
BLOOD;
CARCINOMA;
DRUG EFFECT;
INTRAPERITONEAL DRUG ADMINISTRATION;
LOW LEVEL LASER THERAPY;
MASS SPECTROMETRY;
METHODOLOGY;
PATHOLOGY;
PERITONEUM;
PERITONEUM TUMOR;
RAT;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BIOLOGICAL AVAILABILITY;
CARCINOMA;
INJECTIONS, INTRAPERITONEAL;
LASER THERAPY;
MASS SPECTROMETRY;
ORGANOPLATINUM COMPOUNDS;
PERITONEAL NEOPLASMS;
PERITONEUM;
RATS;
RATTUS;
|
EID: 84858706494
PISSN: 16182642
EISSN: 16182650
Source Type: Journal
DOI: 10.1007/s00216-011-5654-3 Document Type: Article |
Times cited : (51)
|
References (28)
|